[Form 4] Guardant Health, Inc. Insider Trading Activity
Guardant Health (GH) 鈥� Form 4 filing dated 07/02/2025 discloses routine equity activity by Chief Financial Officer Michael Brian Bell linked to previously granted restricted stock units (RSUs).
- On 07/01/2025, 2,084 RSUs vested (code M). These were converted into common shares at no cash cost.
- To satisfy tax-withholding, 1,057 shares were automatically withheld and disposed of at $50.71 per share (code F).
- Net result: the CFO鈥檚 direct common-stock holdings increased by 1,027 shares to 43,028 shares; he retains 10,421 unvested RSUs.
No open-market purchases or discretionary sales occurred; the transactions appear strictly administrative and are consistent with the original three-year vesting schedule of the December 13, 2023 RSU grant.
Guardant Health (GH) 鈥� Comunicazione Form 4 datata 02/07/2025 rivela un'attivit脿 azionaria di routine da parte del Chief Financial Officer Michael Brian Bell, relativa a unit脿 azionarie vincolate (RSU) precedentemente assegnate.
- Il 01/07/2025, 2.084 RSU sono maturate (codice M). Queste sono state convertite in azioni ordinarie senza alcun costo in denaro.
- Per soddisfare la ritenuta fiscale, 1.057 azioni sono state automaticamente trattenute e vendute a 50,71 $ per azione (codice F).
- Risultato netto: la detenzione diretta di azioni ordinarie del CFO 猫 aumentata di 1.027 azioni raggiungendo 43.028 azioni; mantiene 10.421 RSU non maturate.
Non si sono verificate acquisizioni sul mercato aperto n茅 vendite discrezionali; le operazioni appaiono strettamente amministrative e coerenti con il programma di maturazione triennale originario del grant di RSU del 13 dicembre 2023.
Guardant Health (GH) 鈥� Presentaci贸n del Formulario 4 fechada el 02/07/2025 revela una actividad rutinaria de acciones por parte del Director Financiero Michael Brian Bell vinculada a unidades de acciones restringidas (RSU) previamente otorgadas.
- El 01/07/2025, 2,084 RSU se consolidaron (c贸digo M). Estas se convirtieron en acciones comunes sin costo en efectivo.
- Para cubrir la retenci贸n de impuestos, 1,057 acciones fueron retenidas autom谩ticamente y vendidas a $50.71 por acci贸n (c贸digo F).
- Resultado neto: la tenencia directa de acciones comunes del CFO aument贸 en 1,027 acciones hasta 43,028 acciones; conserva 10,421 RSU no consolidadas.
No hubo compras en el mercado abierto ni ventas discrecionales; las transacciones parecen estrictamente administrativas y son consistentes con el calendario original de consolidaci贸n a tres a帽os de la concesi贸n de RSU del 13 de diciembre de 2023.
Guardant Health (GH) 鈥� 2025雲� 7鞗� 2鞚检瀽 Form 4 鞝滌稖鞚� 斓滉碃鞛毂呾瀯鞛� 毵堨澊韥� 敫岆澕鞚挫柛 氩澊 鞚挫爠鞐� 攵�鞐皼鞚� 鞝滍暅 欤检嫕 雼渼(RSU)鞕� 甏�霠悳 鞚检儊鞝侅澑 欤检嫕 瓯半灅毳� 瓿店皽頃╇媹雼�.
- 2025雲� 7鞗� 1鞚�, 2,084 RSU臧� 靹膘垯頄堨姷雼堧嫟(旖旊摐 M). 鞚措姅 順勱笀 牍勳毄 鞐嗢澊 氤错喌欤茧 鞝勴櫂霅橃棃鞀惦媹雼�.
- 靹戈笀 鞗愳矞歆曥垬毳� 於╈”頃橁赴 鞙勴暣 1,057欤缄皜 鞛愲彊鞙茧 鞗愳矞歆曥垬霅橃柎 欤茧嫻 $50.71鞐� 觳橂秳霅橃棃鞀惦媹雼�(旖旊摐 F).
- 靾� 瓴瓣臣: CFO鞚� 歆侅爲 氤挫湢 氤错喌欤缄皜 1,027欤� 歃濌皜顷橃棳 43,028欤�臧� 霅橃棃鞙茧┌, 10,421 RSU電� 鞎勳 靹膘垯頃橃 鞎婌潃 靸來儨鞛呺媹雼�.
瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬雮� 鞛勳潣 毵る弰電� 鞐嗢棃鞙茧┌, 瓯半灅電� 鞐勱博頌� 甏�毽� 氇╈爜鞚措┌ 2023雲� 12鞗� 13鞚� RSU 攵�鞐潣 鞗愲灅 3雲� 靹膘垯 鞚检爼瓿� 鞚检箻頃╇媹雼�.
Guardant Health (GH) 鈥� D茅p么t du Formulaire 4 dat茅 du 02/07/2025 r茅v猫le une activit茅 courante sur actions du Directeur Financier Michael Brian Bell li茅e 脿 des unit茅s d鈥檃ctions restreintes (RSU) pr茅c茅demment attribu茅es.
- Le 01/07/2025, 2 084 RSU ont 茅t茅 acquises (code M). Celles-ci ont 茅t茅 converties en actions ordinaires sans co没t en esp猫ces.
- Pour couvrir la retenue d鈥檌mp么t, 1 057 actions ont 茅t茅 automatiquement retenues et vendues 脿 50,71 $ par action (code F).
- R茅sultat net : la d茅tention directe d鈥檃ctions ordinaires du CFO a augment茅 de 1 027 actions pour atteindre 43 028 actions ; il conserve 10 421 RSU non acquises.
Aucun achat sur le march茅 ouvert ni vente discr茅tionnaire n鈥檃 eu lieu ; les transactions semblent strictement administratives et sont conformes au calendrier d鈥檃cquisition initial de trois ans de l鈥檃ttribution de RSU du 13 d茅cembre 2023.
Guardant Health (GH) 鈥� Form 4 Einreichung vom 02.07.2025 offenbart routinem盲脽ige Aktienaktivit盲ten des Chief Financial Officers Michael Brian Bell im Zusammenhang mit zuvor gew盲hrten Restricted Stock Units (RSUs).
- Am 01.07.2025 sind 2.084 RSUs f盲llig geworden (Code M). Diese wurden ohne Barauszahlung in Stammaktien umgewandelt.
- Zur Befriedigung der Steuerabz眉ge wurden 1.057 Aktien automatisch einbehalten und zu je 50,71 $ ver盲u脽ert (Code F).
- Nettoergebnis: Der direkte Stammaktienbestand des CFO erh枚hte sich um 1.027 Aktien auf 43.028 Aktien; er beh盲lt 10.421 nicht f盲llige RSUs.
Es gab keine K盲ufe am offenen Markt oder diskretion盲re Verk盲ufe; die Transaktionen erscheinen rein administrativ und entsprechen dem urspr眉nglichen dreij盲hrigen Vesting-Zeitplan der RSU-Zuteilung vom 13. Dezember 2023.
- None.
- None.
Insights
TL;DR: Routine RSU vesting; minimal market impact.
The filing documents standard vesting of CFO Bell鈥檚 December 2023 RSU grant. Half the shares were forfeited to cover withholding taxes, a common practice that does not signal a change in sentiment. The net share accretion (鈮�1 k shares) is immaterial relative to Guardant Health鈥檚 ~103 m basic shares outstanding. No cash was raised or paid by the insider, so liquidity and capital-structure metrics remain unchanged. Overall, the event is neutral for valuation and governance.
TL;DR: Administrative insider transaction, governance-neutral.
This Form 4 reflects automatic tax withholding under Rule 16b-3 rather than an elective sale, maintaining alignment between management and shareholders. The continued ownership of 10,421 unvested RSUs preserves long-term incentives. No red flags emerge regarding trading plans or potential misuse of material non-public information. The filing therefore has no meaningful governance implications.
Guardant Health (GH) 鈥� Comunicazione Form 4 datata 02/07/2025 rivela un'attivit脿 azionaria di routine da parte del Chief Financial Officer Michael Brian Bell, relativa a unit脿 azionarie vincolate (RSU) precedentemente assegnate.
- Il 01/07/2025, 2.084 RSU sono maturate (codice M). Queste sono state convertite in azioni ordinarie senza alcun costo in denaro.
- Per soddisfare la ritenuta fiscale, 1.057 azioni sono state automaticamente trattenute e vendute a 50,71 $ per azione (codice F).
- Risultato netto: la detenzione diretta di azioni ordinarie del CFO 猫 aumentata di 1.027 azioni raggiungendo 43.028 azioni; mantiene 10.421 RSU non maturate.
Non si sono verificate acquisizioni sul mercato aperto n茅 vendite discrezionali; le operazioni appaiono strettamente amministrative e coerenti con il programma di maturazione triennale originario del grant di RSU del 13 dicembre 2023.
Guardant Health (GH) 鈥� Presentaci贸n del Formulario 4 fechada el 02/07/2025 revela una actividad rutinaria de acciones por parte del Director Financiero Michael Brian Bell vinculada a unidades de acciones restringidas (RSU) previamente otorgadas.
- El 01/07/2025, 2,084 RSU se consolidaron (c贸digo M). Estas se convirtieron en acciones comunes sin costo en efectivo.
- Para cubrir la retenci贸n de impuestos, 1,057 acciones fueron retenidas autom谩ticamente y vendidas a $50.71 por acci贸n (c贸digo F).
- Resultado neto: la tenencia directa de acciones comunes del CFO aument贸 en 1,027 acciones hasta 43,028 acciones; conserva 10,421 RSU no consolidadas.
No hubo compras en el mercado abierto ni ventas discrecionales; las transacciones parecen estrictamente administrativas y son consistentes con el calendario original de consolidaci贸n a tres a帽os de la concesi贸n de RSU del 13 de diciembre de 2023.
Guardant Health (GH) 鈥� 2025雲� 7鞗� 2鞚检瀽 Form 4 鞝滌稖鞚� 斓滉碃鞛毂呾瀯鞛� 毵堨澊韥� 敫岆澕鞚挫柛 氩澊 鞚挫爠鞐� 攵�鞐皼鞚� 鞝滍暅 欤检嫕 雼渼(RSU)鞕� 甏�霠悳 鞚检儊鞝侅澑 欤检嫕 瓯半灅毳� 瓿店皽頃╇媹雼�.
- 2025雲� 7鞗� 1鞚�, 2,084 RSU臧� 靹膘垯頄堨姷雼堧嫟(旖旊摐 M). 鞚措姅 順勱笀 牍勳毄 鞐嗢澊 氤错喌欤茧 鞝勴櫂霅橃棃鞀惦媹雼�.
- 靹戈笀 鞗愳矞歆曥垬毳� 於╈”頃橁赴 鞙勴暣 1,057欤缄皜 鞛愲彊鞙茧 鞗愳矞歆曥垬霅橃柎 欤茧嫻 $50.71鞐� 觳橂秳霅橃棃鞀惦媹雼�(旖旊摐 F).
- 靾� 瓴瓣臣: CFO鞚� 歆侅爲 氤挫湢 氤错喌欤缄皜 1,027欤� 歃濌皜顷橃棳 43,028欤�臧� 霅橃棃鞙茧┌, 10,421 RSU電� 鞎勳 靹膘垯頃橃 鞎婌潃 靸來儨鞛呺媹雼�.
瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬雮� 鞛勳潣 毵る弰電� 鞐嗢棃鞙茧┌, 瓯半灅電� 鞐勱博頌� 甏�毽� 氇╈爜鞚措┌ 2023雲� 12鞗� 13鞚� RSU 攵�鞐潣 鞗愲灅 3雲� 靹膘垯 鞚检爼瓿� 鞚检箻頃╇媹雼�.
Guardant Health (GH) 鈥� D茅p么t du Formulaire 4 dat茅 du 02/07/2025 r茅v猫le une activit茅 courante sur actions du Directeur Financier Michael Brian Bell li茅e 脿 des unit茅s d鈥檃ctions restreintes (RSU) pr茅c茅demment attribu茅es.
- Le 01/07/2025, 2 084 RSU ont 茅t茅 acquises (code M). Celles-ci ont 茅t茅 converties en actions ordinaires sans co没t en esp猫ces.
- Pour couvrir la retenue d鈥檌mp么t, 1 057 actions ont 茅t茅 automatiquement retenues et vendues 脿 50,71 $ par action (code F).
- R茅sultat net : la d茅tention directe d鈥檃ctions ordinaires du CFO a augment茅 de 1 027 actions pour atteindre 43 028 actions ; il conserve 10 421 RSU non acquises.
Aucun achat sur le march茅 ouvert ni vente discr茅tionnaire n鈥檃 eu lieu ; les transactions semblent strictement administratives et sont conformes au calendrier d鈥檃cquisition initial de trois ans de l鈥檃ttribution de RSU du 13 d茅cembre 2023.
Guardant Health (GH) 鈥� Form 4 Einreichung vom 02.07.2025 offenbart routinem盲脽ige Aktienaktivit盲ten des Chief Financial Officers Michael Brian Bell im Zusammenhang mit zuvor gew盲hrten Restricted Stock Units (RSUs).
- Am 01.07.2025 sind 2.084 RSUs f盲llig geworden (Code M). Diese wurden ohne Barauszahlung in Stammaktien umgewandelt.
- Zur Befriedigung der Steuerabz眉ge wurden 1.057 Aktien automatisch einbehalten und zu je 50,71 $ ver盲u脽ert (Code F).
- Nettoergebnis: Der direkte Stammaktienbestand des CFO erh枚hte sich um 1.027 Aktien auf 43.028 Aktien; er beh盲lt 10.421 nicht f盲llige RSUs.
Es gab keine K盲ufe am offenen Markt oder diskretion盲re Verk盲ufe; die Transaktionen erscheinen rein administrativ und entsprechen dem urspr眉nglichen dreij盲hrigen Vesting-Zeitplan der RSU-Zuteilung vom 13. Dezember 2023.
FAQ
How many Guardant Health shares does CFO Michael Brian Bell now own?
What triggered the Form 4 filing for GH on 07/02/2025?
Did the CFO sell Guardant Health shares for personal gain?
How many restricted stock units remain unvested for the CFO?
Is the transaction likely to affect GH鈥檚 share price?
